Table of Contents Table of Contents
Previous Page  30 / 42 Next Page
Information
Show Menu
Previous Page 30 / 42 Next Page
Page Background

30

Aflibercept es eficaz (OS, PFS)

independientemente del estado KRASex2

(WT y Mut)

WT

MUT

Wirapati, P. (2017, Mayo)

VELOUR trial biomarkers update: Impact of RAS, BRAF, and sidedness on aflibercept activity

Poster presentado en ASCO Chicago, USA.